Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Dec 21, 2021 2:21pm
69 Views
Post# 34251496

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Omicron

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Omicron...and the ability of more bodies to work as petri-dishes for the next more transmissable and more severe version, which will ultimately end up as something perhaps as deadly as something like Ebola according to the WMA. Even if a vaccine isn't 100% at keeping it out (but still 100% at living thorugh it), it still minimizes the bodies it needs for mutations immensely.


jfm1330 wrote: I was giving the example of Quebec as something positive with our 4 deaths per day for 8.5 M of population, with 90% vaccination rate for those 12 or older. But imagine if we would have mandatory vaccination (significative fines for the unvaxed), our vaccination rate would be somewhere above 97% and we would not have more than one death per day on average, probably less. We still have 4 deaths per day because of our 10 % of unvaxed people. Deniers, conspirasionists and selfish people can say what they want, the facts are stubborn. The higher the vaccination rate is, the more lives are saved. This is the reality, and here, people will rush to get the third dose. It will help to minimize the number of deaths when omicron will totally take over with its very high transmisibility.




<< Previous
Bullboard Posts
Next >>